Nasdaq

Avalon GloboCare Advances Next Generation Cellular Immunotherapy with FLASH-CAR™ Technology for Blood Cancers

FREEHOLD, N.J., May 08, 2020 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a clinical-stage global developer of cell-based technologies and therapeutics, announced today that it has ...
Nasdaq

Avalon GloboCare Corp. Secures Patent for Proprietary CAR-T and CAR-NK Cell Technology in Hong Kong

Avalon GloboCare secures a patent in Hong Kong for CAR-T and CAR-NK cell technology, enhancing its global intellectual property portfolio. Avalon GloboCare Corp. announced that it has been granted a ...
Seeking Alpha

Avalon GloboCare Announces Patent Issuance for Novel CAR-T and CAR-NK Cell Technology in Hong Kong

FREEHOLD, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (ALBT), a developer of precision diagnostic consumer products, today announced the issuance of a new standard patent by the ...
Benzinga.com

EXCLUSIVE: Avalon GloboCare Buys AI Video Firm In $19.5 Million Deal

Avalon GloboCare Corp. (NASDAQ: ALBT) announced Monday that it has acquired RPM Interactive, Inc., a generative artificial intelligence software company, through an all-stock transaction. The ...
Business Insider

Avalon GloboCare Advances Next Generation Cellular Immunotherapy with FLASH-CAR™ Technology for Blood Cancers

RNA-Based Chimeric Antigen Receptor (CAR) Design Compatible with Broad Range of Immune Effector Cells, Including T (CAR-T) and Natural Killer Cells (CAR-NK) Without the Use of Viral Vectors Capable of ...